OVARIAN CANCER and US: alternative

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label alternative. Show all posts
Showing posts with label alternative. Show all posts

Tuesday, January 03, 2012

Attitudes of Patients With Gynecological and Breast Cancer Toward Integration of Complementary Medicine in Cancer Care



Conclusion:
Although patients with gynecological malignancies use CAM significantly more than patients with breast cancer, both groups share similar conceptions regarding the active role of their gynecologist oncologists in the process of CAM integration within supportive care and expect CAM consultation to focus on improving their well-being.

Monday, August 22, 2011

Pilot Program to Personalize Care & Improve Quality of Life for Women With Recurrent Ovarian Cancer - Full Text View - ClinicalTrials.gov (CAM)



 This study is currently recruiting participants.
Verified on August 2011

First Received on August 16, 2011.   Last Updated on August 17, 2011
Purpose
The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with recurrent ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only a few of these alternative medicines have been tested with women with ovarian cancer.

Monday, April 19, 2010

FR Doc 2010-8386 Falsification of Data- complentary and alternative medicine NCCAM



U.S.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.

"...research  misconduct in research supported by National Center for Complementary
and Alternative Medicine (NCCAM), National Institutes of Health (NIH),
grant R01 AT001846 and Predoctoral Fellowship Award F31 AT003977-01,
and National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), NIH, grant R01 DK082773-01."